Namouni Fouad 4
4 · Blueprint Medicines Corp · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Namouni Fouad
PRESIDENT, R & D
Transactions
- Award
Common Stock
[F1]2025-03-01+13,200→ 82,270 total - Award
Stock Option (Right to Buy)
[F2]2025-03-01+26,400→ 26,400 totalExercise: $96.57Exp: 2035-02-28→ Common Stock (26,400 underlying)
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of grant of 13,200 restricted stock units under the Issuer's 2024 Stock Incentive Plan.
- [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2025 and as to an additional 1/48th of the shares underlying the option each month thereafter.
Signature
/s/ Melissa Masse, Attorney-in-Fact|2025-03-04